Surgeon in battle with Johnson & Johnson over spine tech


A leading British surgeon is seeking payment from US medical giant Johnson & Johnson in a long-running dispute over the development of spinal implants.

John Webb, 82, who was also a doctor to the Royal Family, says he and a Swiss colleague were not paid by the beneficiaries of their trailblazing work.

The implants are now owned by Johnson & Johnson after a complex series of mergers over more than 20 years.

Webb and his colleague, who does not wish to be named, designed the cutting-edge devices, trademarked under the brand name Synthes, between 1987 and 2005 while they were working for the AO Foundation research organisation in Switzerland.

Trailblazing work: A leading British surgeon is seeking payment from US medical giant Johnson & Johnson in a long-running dispute over the development of spinal implants

Trailblazing work: A leading British surgeon is seeking payment from US medical giant Johnson & Johnson in a long-running dispute over the development of spinal implants

Swiss billionaire Hansjorg Wyss, 89, a co-owner of Chelsea Football Club, bought the rights to Synthes devices from AO for £900 million in 2006. Webb and his colleague claim they unknowingly signed over their intellectual property at that time.

Johnson & Johnson then bought Wyss’s firm in 2012 in a £16 billion deal. A Johnson & Johnson spokesman said: ‘We have thoroughly reviewed the materials submitted by the claimants. Our assessment confirms that there is no basis for their claim.’

DIY INVESTING PLATFORMS

Easy investing and ready-made portfolios

AJ Bell

Easy investing and ready-made portfolios

AJ Bell

Easy investing and ready-made portfolios

Free fund dealing and investment ideas

Hargreaves Lansdown

Free fund dealing and investment ideas

Hargreaves Lansdown

Free fund dealing and investment ideas

Flat-fee investing from £4.99 per month

interactive investor

Flat-fee investing from £4.99 per month

interactive investor

Flat-fee investing from £4.99 per month

Account and trading fee-free ETF investing

InvestEngine

Account and trading fee-free ETF investing

InvestEngine

Account and trading fee-free ETF investing

Free share dealing and no account fee

Trading 212

Free share dealing and no account fee

Trading 212

Free share dealing and no account fee

Affiliate links: If you take out a product This is Money may earn a commission. These deals are chosen by our editorial team, as we think they are worth highlighting. This does not affect our editorial independence.

Compare the best investing account for you





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *